TrialJournal of nuclear medicine : official publication, Society of Nuclear Medicine2012

3'-deoxy-3'-18F-fluorothymidine PET and MRI for early survival predictions in patients with recurrent malignant glioma treated with bevacizumab.

Johannes Schwarzenberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.